ALNOV:EPA
Novacyt SA
0,41 €
arrow_downward
-0,37%(-0,0015) 1K
6-noy, 9:59:20 (GMT+1) · EUR
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoALNOV tikeri uchun statistika yaratilmoqda...
Ochish
0,41 €
Yuqori
0,41 €
Past
0,41 €
Bozor kapitali
29,38 mln
Oʻrtacha hajm
187,71 ming
Hajmi
28,00 ming
52 haftalik eng yuqori
1,04 €
52 haftalik eng past
0,29 €
Aksiya boʻyicha daromad
-0,38 €
Muomaladagi aksiyalar
72,59 mln
Xodimlar soni
228
Ochish
0,41 €
Yuqori
0,41 €
Past
0,41 €
Bozor kapitali
29,38 mln
Oʻrtacha hajm
187,71 ming
Hajmi
28,00 ming
52 haftalik eng yuqori
1,04 €
52 haftalik eng past
0,29 €
Aksiya boʻyicha daromad
-0,38 €
Muomaladagi aksiyalar
72,59 mln
Xodimlar soni
228
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
TradingView
·
1 soat oldin
Key facts: NASDAQ:ARQT Starts Phase 3 Trial; Target Rises to $39.62
The Motley Fool
·
26 daqiqa oldin
The Nasdaq Just Hit Correction Territory. History Says the Stock Market Will Do This Next (Hint: It May Stun You)
MarketWatch
·
10 soat oldin
Tech stocks log worst day since 2020 as carnage comes to the AI trade
WSJ
·
13 soat oldin
Your House vs. the Stock Market: Which Has Been a Better Investment?
Profil
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
Novacyt SA haqida
CEODavid Allmond
Xodimlar soni228
Asos solingan3-iyl, 2006
Bosh ofislar-
SektorHealth Care
Industry-
Veb-saytnovacyt.com